Detrothyronine

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 592457

CAS#: 5714-08-9

Description: Detrothyronine is a biochemical.

Chemical Structure

img
Detrothyronine
CAS# 5714-08-9
Instruction

Theoretical Analysis

MedKoo Cat#: 592457
Name: Detrothyronine
CAS#: 5714-08-9
Chemical Formula: C15H12I3NO4
Exact Mass: 650.79
Molecular Weight: 650.980
Elemental Analysis: C, 27.68; H, 1.86; I, 58.48; N, 2.15; O, 9.83

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Detrothyronine; NSC 46046; NSC-46046; NSC46046

IUPAC/Chemical Name: Alanine, 3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-, D- (8CI)

InChi Key: AUYYCJSJGJYCDS-LBPRGKRZSA-N

InChi Code: InChI=1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1

SMILES Code: N[C@@H](CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)C(O)=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 650.98 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Hine C, Kim HJ, Zhu Y, Harputlugil E, Longchamp A, Matos MS, Ramadoss P, Bauerle K, Brace L, Asara JM, Ozaki CK, Cheng SY, Singha S, Ahn KH, Kimmelman A, Fisher FM, Pissios P, Withers DJ, Selman C, Wang R, Yen K, Longo VD, Cohen P, Bartke A, Kopchick JJ, Miller R, Hollenberg AN, Mitchell JR. Hypothalamic-Pituitary Axis Regulates Hydrogen Sulfide Production. Cell Metab. 2017 Jun 6;25(6):1320-1333.e5. doi: 10.1016/j.cmet.2017.05.003. PubMed PMID: 28591635; PubMed Central PMCID: PMC5722247.

2: Chaker L, Baumgartner C, den Elzen WP, Collet TH, Ikram MA, Blum MR, Dehghan A, Drechsler C, Luben RN, Portegies ML, Iervasi G, Medici M, Stott DJ, Dullaart RP, Ford I, Bremner A, Newman AB, Wanner C, Sgarbi JA, Dörr M, Longstreth WT Jr, Psaty BM, Ferrucci L, Maciel RM, Westendorp RG, Jukema JW, Ceresini G, Imaizumi M, Hofman A, Bakker SJ, Franklyn JA, Khaw KT, Bauer DC, Walsh JP, Razvi S, Gussekloo J, Völzke H, Franco OH, Cappola AR, Rodondi N, Peeters RP; Thyroid Studies Collaboration. Thyroid Function Within the Reference Range and the Risk of Stroke: An Individual Participant Data Analysis. J Clin Endocrinol Metab. 2016 Nov;101(11):4270-4282. Epub 2016 Sep 7. PubMed PMID: 27603906; PubMed Central PMCID: PMC5095234.

3: Yang S, Shi FT, Leung PC, Huang HF, Fan J. Low Thyroid Hormone in Early Pregnancy Is Associated With an Increased Risk of Gestational Diabetes Mellitus. J Clin Endocrinol Metab. 2016 Nov;101(11):4237-4243. Epub 2016 Sep 1. PubMed PMID: 27583471.

4: Pearce SH, Razvi S, Yadegarfar ME, Martin-Ruiz C, Kingston A, Collerton J, Visser TJ, Kirkwood TB, Jagger C. Serum Thyroid Function, Mortality and Disability in Advanced Old Age: The Newcastle 85+ Study. J Clin Endocrinol Metab. 2016 Nov;101(11):4385-4394. Epub 2016 Aug 23. PubMed PMID: 27552542; PubMed Central PMCID: PMC5095241.

5: Unüvar T, Anık A, Catlı G, Esen I, Abacı A, Büyükgebiz A, Böber E. Isolated hyperthyrotropinemia in childhood obesity and its relation with metabolic parameters. J Endocrinol Invest. 2014 Sep;37(9):799-804. doi: 10.1007/s40618-014-0100-y. Epub 2014 Jun 12. PubMed PMID: 24920280.

6: Kundu S, Pramanik M, Roy S, De J, Biswas A, Ray AK. Maintenance of brain thyroid hormone level during peripheral hypothyroid condition in adult rat. Life Sci. 2006 Sep 5;79(15):1450-5. Epub 2006 Apr 25. PubMed PMID: 16698041.

7: Visser TJ. The elemental importance of sufficient iodine intake: a trace is not enough. Endocrinology. 2006 May;147(5):2095-7. PubMed PMID: 16617153.

8: Ercan O. Thyroid Hormone Resistance in children. Pediatr Endocrinol Rev. 2003 Dec;1 Suppl 2:191-8; discussion 198. Review. PubMed PMID: 16444158.

9: Denke MA. Diet, lifestyle, and nonstatin trials: review of time to benefit. Am J Cardiol. 2005 Sep 5;96(5A):3F-10F. Review. PubMed PMID: 16126018.

10: Sarkissian G, Dace A, Mesmacque A, Bony-Trifunovic H, Malezet-Desmoulins C, Torresani J, Margotat A. A novel resistance to thyroid hormone associated with a new mutation (T329N) in the thyroid hormone receptor beta gene. Thyroid. 1999 Feb;9(2):165-71. PubMed PMID: 10090317.

11: Lin HY, Martino LJ, Wilcox BD, Davis FB, Gordinier JK, Davis PJ. Potentiation by thyroid hormone of human IFN-gamma-induced HLA-DR expression. J Immunol. 1998 Jul 15;161(2):843-9. PubMed PMID: 9670962.

12: Bommer C, Werle E, Walter-Sack I, Keller C, Gehlen F, Wanner C, Nauck M, März W, Wieland H, Bommer J. D-thyroxine reduces lipoprotein(a) serum concentration in dialysis patients. J Am Soc Nephrol. 1998 Jan;9(1):90-6. PubMed PMID: 9440092.

13: Pohlenz J, Knöbl D. Treatment of pituitary resistance to thyroid hormone (PRTH) in an 8-year-old boy. Acta Paediatr. 1996 Mar;85(3):387-90. PubMed PMID: 8696005.

14: Gould AL, Rossouw JE, Santanello NC, Heyse JF, Furberg CD. Cholesterol reduction yields clinical benefit. A new look at old data. Circulation. 1995 Apr 15;91(8):2274-82. PubMed PMID: 7697857.

15: Narihara R, Hirouchi M, Ichida T, Kuriyama K, Roberts E. Effects of thyroxine and its related compounds on cerebral GABA receptors: inhibitory action on benzodiazepine recognition site in GABAA receptor complex. Neurochem Int. 1994 Nov;25(5):451-4. PubMed PMID: 7849573.

16: Karlsson FA, Burman P, Kämpe O, Westlin JE, Wide L. Large somatostatin-insensitive thyrotrophin-secreting pituitary tumour responsive to D-thyroxine and dopamine agonists. Acta Endocrinol (Copenh). 1993 Oct;129(4):291-5. PubMed PMID: 7901958.

17: Hamon P, Dingeon B, Jiang NS, Orgiazzi J. Purified D-thyroxine in athyreotic patients. Lancet. 1993 Jun 5;341(8858):1477. PubMed PMID: 8099168.

18: Schwartz ID, Bercu BB. Dextrothyroxine in the treatment of generalized thyroid hormone resistance in a boy homozygous for a defect in the T3 receptor. Thyroid. 1992 Spring;2(1):15-9. PubMed PMID: 1525565.

19: Aguilar Diosdado M, Escobar-Jimenez L, Fernandez Soto ML, Garcia Curiel A, Escobar-Jimenez F. Hyperthyroidism due to familial pituitary resistance to thyroid hormone: successful control with 3, 5, 3' triiodothyroacetic associated to propranolol. J Endocrinol Invest. 1991 Sep;14(8):663-8. PubMed PMID: 1774450.

20: Sandhu GS, Steele R, Gonnella NC. Effect of L-thyroxine (LT4) and D-thyroxine (DT4) on cardiac function and high-energy phosphate metabolism: a 31P NMR study. Magn Reson Med. 1991 Mar;18(1):237-43. PubMed PMID: 2062236.